Literature DB >> 9093636

Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.

R Nonata1, R Sampaio, P D Marsden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9093636     DOI： 10.1016/s0035-9203(97)90404-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  11 in total

1.  A cluster of cutaneous leishmaniasis associated with human smuggling.

Authors:  Anthony P Cannella; Bichchau M Nguyen; Caroline D Piggott; Robert A Lee; Joseph M Vinetz; Sanjay R Mehta
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?

Authors:  Valdir S Amato; Felipe F Tuon; Raphael A Camargo; Regina M Souza; Carolina R Santos; Antonio C Nicodemo
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

3.  Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.

Authors:  Mirella A Cunha; Aline C Q Leão; Rita de Cassia Soler; José Angelo L Lindoso
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

4.  Cutaneous leishmaniasis in Cuban immigrants to Texas who traveled through the Darién Jungle, Panama.

Authors:  Meagan A Barry; Misha V Koshelev; Grace S Sun; Sarah J Grekin; Charles E Stager; A Hafeez Diwan; Carina A Wasko; Kristy O Murray; Laila Woc-Colburn
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

Review 5.  Practical guide for the treatment of leishmaniasis.

Authors:  R N Davidson
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

6.  Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru.

Authors:  Braulio M Valencia; David Miller; Richard S Witzig; Andrea K Boggild; Alejandro Llanos-Cuentas
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

Review 7.  Cutaneous leishmaniasis: recent developments in diagnosis and management.

Authors:  Henry J C de Vries; Sophia H Reedijk; Henk D F H Schallig
Journal:  Am J Clin Dermatol       Date:  2015-04       Impact factor: 7.403

8.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

9.  Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.

Authors:  Carolina Rocio Santos; Felipe Francisco Tuon; Juliette Cieslinski; Regina Maia de Souza; Rui Imamura; Valdir Sabbaga Amato
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

10.  Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.

Authors:  Carlos Franco-Muñoz; Merab Manjarrés-Estremor; Clemencia Ovalle-Bracho
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.